Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience
Ann Allergy Asthma Immunol
.
2015 Dec;115(6):536.
doi: 10.1016/j.anai.2015.09.012.
Authors
Luis Felipe Ensina
1
,
Alex Eustáquio de Lacerda
2
,
Ligia Maria de Oliveira Machado
2
,
Inês Camelo-Nunes
3
,
Dirceu Solé
2
Affiliations
1
Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil. Electronic address: 100alergia@gmail.com.
2
Federal University of São Paulo, São Paulo, Brazil.
3
Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil.
PMID:
26653279
DOI:
10.1016/j.anai.2015.09.012
No abstract available
Publication types
Letter
MeSH terms
Adult
Anti-Allergic Agents / therapeutic use*
Chronic Disease
Female
Humans
Male
Omalizumab / therapeutic use*
Treatment Outcome
Urticaria / drug therapy*
Substances
Anti-Allergic Agents
Omalizumab